DSM eyes generic omega-3 drug space with €420m ONC buy
date:May 21, 2012
p to C$60m (46m). The business has grown by about 20% per year for the past five years buoyed by bulging US supplement sales and growing numbers of functional foods using its MEG-3 branded ingredient.


Feike Sijbesma, CEO and chairman of the DSM Managing Board, said in a statement: After our successful acquisition of Martek in 2011, the acquisition of Ocean Nutrition Canada is the logical next step in developing our Nutritional Lipids into a major growth platform for our Nutrition cluster.


It
6/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
01/10 16:32